Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Clinical trial NCT00892736 · COMPLETED

Trial details

NCT number: NCT00892736
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Basal-Like Breast Carcinoma BRCA1 Mutation Carrier BRCA2 Mutation Carrier Breast Carcinoma Estrogen Receptor Negative HER2/Neu Negative Hereditary Breast and Ovarian Cancer Syndrome Ovarian Carcinoma Pancreatic Carcinoma Progesterone Receptor Negative Prostate Carcinoma Recurrent Breast Carcinoma

Start date: 2009-04-20
Primary completion: 2017-05-19
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.